Cointime

Protillion Biosciences

company

About

Protillion Biosciences specializes in the design and development of protein-based drugs.

Highlights

Total Funding Amount
$18M
Funding Rounds
1
Investors
2
Employee Profiles
3

Details

Last Funding Type
Series A
Last Funding Money Raised
$18M
Industries
Biopharma,Biotechnology,Genetics
Founded date
Jan 1, 2019
Number Of Employee
1 - 10
Operating Status
Active
Also Known As
Protillion

Protillion Biosciences is a biotech company commercializing disruptive technology for therapeutic antibody and drug discovery and accelerating biologic research and development productivity.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$18M
Protillion Biosciences has raised a total of $18M in funding over 2 rounds. Their latest funding was raised on Dec 19, 2022 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 19, 2022 Series A $18M 2 ARCH Venture Partners
Illumina Ventures 		— Detail

Investors

Number of Lead Investors
Number of Investors
2
2
Protillion Biosciences is funded by 2 investors. ARCH Venture Partners and Illumina Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
ARCH Venture Partners Yes Series A
Illumina Ventures Yes Series A

Employee Profiles

Number of Employee Profiles
3
Protillion Biosciences has 3 current employee profiles, including Board member David R. Walt
David R. Walt
Board member
Curtis Layton
Executive
William Greenleaf
Executive
Cointime
Содержание
компания